Report - Secukinumab shows significant efficacy in palmoplantar ... · Secukinumab 300 mg consistently showed the best outcomes. The safety profile was favorable and similar to previous studies.

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form